Trial intelligence / Profile preview

Salbutamol Tolerance to Bronchoprotection in Asthma

NCT01338311Phase 4Completed

Sponsor
University of Saskatchewan
Start
Mar 2011
Primary completion
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of salbutamol in asthma, sponsored by University of Saskatchewan. Started Mar 2011; status: completed.

02

Drugs

salbutamol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01338311.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01338311.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call